Vical's H1N1 vaccines tested

According to SignOnSanDiego.com, Vical has tested their H1N1 flu vaccines on animals, and found the tests to be successful. Their delivery method is unique, injecting genetic material, such as DNA or RNA, that expresses a protein that induces an immune response. This method is successful on animals, but has not yet been marketed for humans.

The Vaccines Development Forum has released their updated agenda, which includes new sessions that will specifically discuss how the vaccines field is responding to the need of rapid vaccine development for the H1N1 vaccine. Check out the PDF here.

To connect with more professionals in the Vaccines field, join our Vaccines Development Forum Group on LinkedIn or join us in Boston September 23-25 for the Vaccines Development Forum.

Share this article with your social network, just click below to share now!

Share |